What Researchers Did
The researchers measured eye pressure, corneal thickness, and the thickness of the retinal nerve fiber layer in people with type 2 diabetes who were getting hyperbaric oxygen therapy (HBOT) for a diabetic foot ulcer.
What They Found
In this prospective, non-randomized cohort study of 46 eyes from 46 patients with type 2 diabetes who received 30 HBOT sessions, average eye pressure rose from baseline (p less than 0.001) while corneal thickness and retinal nerve fiber layer thickness showed no significant change. Measurements were taken at baseline, after sessions 10, 20 and 30, and 3 months after the last session. Eye pressure went above 21 mmHg (between 22 and 28 mmHg) in seven eyes (15.2%). Patients with pressure above 21 mmHg had higher average hemoglobin A1c values than the others (8.2 versus 7.4, p = 0.001).
What This Means for Canadian Patients
For people with type 2 diabetes who are getting HBOT for a diabetic foot ulcer, this study found that eye pressure rose during treatment in some patients, mostly those with higher A1c values. The authors report that corneal thickness and nerve fiber layer thickness did not change. Because there was no comparison group, the study cannot show that HBOT caused these changes, and patients may wish to ask their care team about eye checks.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a brief report of a non-randomized cohort with no comparison group and only 3 months of follow-up after treatment, and the authors call for longer studies of how HBOT affects corneal thickness, eye pressure, and the retinal nerve fiber layer.